Our inpatient C Diff rates have been creeping up. We are currently trying to use a new algorithm to go about testing via rectal swap for colonization purposes vs stool culture. Anyone having this issue? We empirically treated a patient with Vanc OS for 10 days because we inadvertently tested a stool culture because he was having >3 loose stools and he was positive. However, we are not resulting him out but we are treating him.

Our inpatient C Diff rates have been creeping up. We are currently trying to use a new algorithm to go about testing via rectal swap for colonization purposes vs stool culture. Anyone having this issue? We empirically treated a patient with Vanc OS for 10 days because we inadvertently tested a stool culture because he was having >3 loose stools and he was positive. However, we are not resulting him out but we are treating him.

My organization has recently been approached by Hikma representatives regarding Tyzavan. Some of you may recall the Vanco Ready or "Xellia" premix bags of vancomycin (NDC 70594-041-01, among others), which were acquired by Hikma a while back. These products have an advantage as room temperature premixes of vancomycin, which is fairly unique.

Looking to see what other sites have implemented to prevent administration errors with vancomycin.

We currently use a pharmacist managed vancomycin program, where the pharmacists order and time the trough/random levels, and dose adjust as appropriate.